MedTrace Logo

Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry

NCT04414332 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2020-06-04

No results posted yet for this study

Summary

Venous thromboembolic disease is a significant cause of morbidity and mortality. The purpose of the RAPID registry is to collect information on the Angiovac procedure and Angiovac device used in the treatment of deep venous thrombosis (DVT), right heart pathology and pulmonary embolism.

Conditions

  • Venous Thromboembolic Disease
  • Deep Venous Thrombosis
  • Right Heart Pathology
  • Pulmonary Embolism

Interventions

OTHER

Data collection only

This registry is to capture high quality patient safety and effectiveness data on use of the Angiovac device for 3 separate, but overlapping conditions; a) Iliofemoral and Caval DVT, b) Right heart masses, and c) PE. The goal will be achieved by capturing a concise set of immediate and short-term functional and clinical outcome data for all patients who have the angiovac catheter deployed into the vascular system.

Sponsors & Collaborators

Principal Investigators

  • John Moriarty, MD · Professor

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2020-02-27
Completion
2020-02-27

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04414332 on ClinicalTrials.gov